Can I take Wegovy for one month and still see results?

What the trial data says about short-term Wegovy use

The pivotal STEP 1 study, published in the New England Journal of Medicine, followed 1,961 adults over 68 weeks. Average body-weight reduction at the 2.4 mg maintenance dose was around 15%. That number reflects the full duration of treatment, not a snapshot at week four. In the early weeks, weight change is modest; the dose is low, appetite suppression is building, and the body is still adjusting to the medicine. If you are wondering whether you can take Wegovy for just one month and still see meaningful results, the trial data suggests that expecting a month to replicate results that took over a year in a controlled trial is the wrong frame.

The titration schedule matters here. Treatment begins at 0.25 mg, held for approximately four weeks as a settling-in phase. The next step is 0.5 mg, then 1.0 mg, then 1.7 mg, before reaching 2.4 mg, the dose where most of the clinical benefit in the trials was recorded. Working through that ladder takes a minimum of about 16 weeks. So at the one-month mark, many people are still on the first or second rung. Comparing a month's experience against the trial's headline figure is like judging a book by the cover page.

The NICE appraisal of semaglutide (TA875) is telling on this point: its own stopping rule kicks in at six months at the maintenance dose, not at one month from the start. Reaching that maintenance dose is itself a four-month process for most people.

What one month does (and does not) give you

One month of Wegovy is not wasted. It is a real data point. Some people find the first few weeks difficult: nausea, changes in appetite, occasional fatigue. Others settle in quickly and notice appetite shifting within days. That early window is genuinely informative about tolerability, it tells your prescriber whether the dose is being handled well enough to continue titrating upward.

What it does not give you is a fair test of whether Wegovy will help you lose a clinically meaningful amount of weight. The medicine's mechanism (slowing gastric emptying, reducing appetite signals through GLP-1 receptor activation) takes time to produce sustained change. Stopping at four weeks is rather like leaving a course of physiotherapy after the first session because your knee still hurts.

If you are weighing whether to commit to a longer course, our Wegovy treatment overview sets out what a realistic treatment journey looks like, including what to discuss with your prescriber at each stage.

Eligibility: who can start Wegovy in the first place

Before the duration question comes the eligibility question. Wegovy is licensed for adults with a BMI of 30 or above, or 27 to 29.9 with at least one weight-related health condition such as high blood pressure, type 2 diabetes or high cholesterol. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The BMI requirements for Wegovy page covers this in more detail.

Eligibility is assessed by a prescriber, BMI alone does not guarantee approval. Medical history, current medicines and overall health picture are all part of the clinical review. At nume, that review is carried out by a GPhC-registered Independent Prescriber on the same day you submit your consultation. The prescriber, not an algorithm, makes the decision. This matters especially if you are considering treatment for a short window: a prescriber who knows your full picture can advise honestly on whether a short course is appropriate or whether there is a better plan.

A useful starting point before your consultation is the NHS BMI calculator, which gives you a baseline figure to bring to the clinical conversation.

Stopping early: what to expect and what to discuss

People do stop Wegovy before reaching maintenance dose, because of side effects, because circumstances change, or simply because they decide it is not for them. That is a clinical decision to make with your prescriber, not something to do unannounced. Side effects on the starter dose are usually gastrointestinal: nausea, loose stools, indigestion, occasional burping. They tend to ease as the body adjusts. If you are also asking whether taking Wegovy once a month is a viable approach, it is worth knowing that stopping and restarting later is possible but restarts the tolerability process from the beginning.

One practical thing worth knowing: if you order by 12pm on a weekday, dispatch happens the same day once your prescription is approved, arriving the next working day. Planning ahead matters, because gaps in supply (whether from stopping or from a delayed order) do affect how the titration timeline lands. Gaps mid-titration mean the prescriber may recommend stepping back down a dose level before resuming, extending the timeline further.

If your question is really about whether a three-month course makes more sense than a single month, the evidence supports that framing: taking Wegovy for three months gets you closer to, or into, the early therapeutic dose range. Our Wegovy pricing page sets out what is included in treatment costs so you can plan without surprises. And if you have broader questions about what starting treatment involves, our FAQs cover the most common ones our prescribers hear.